The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial

BACKGROUND: This study assessed the ability of mid-regional proadrenomedullin (MR-proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive protein) and clinical scores to identify disease severity in patients with sepsis. METHODS: This is a secondary analysis of a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Elke, Gunnar, Bloos, Frank, Wilson, Darius Cameron, Brunkhorst, Frank Martin, Briegel, Josef, Reinhart, Konrad, Loeffler, Markus, Kluge, Stefan, Nierhaus, Axel, Jaschinski, Ulrich, Moerer, Onnen, Weyland, Andreas, Meybohm, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863464/
https://www.ncbi.nlm.nih.gov/pubmed/29562917
http://dx.doi.org/10.1186/s13054-018-2001-5

Ejemplares similares

Ejemplares similares